Cargando…

Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease

PURPOSE: To assess patient satisfaction among current and former users of the anti-inflammatory topical medications, cyclosporine A 0.05% (CYC) and lifitegrast 5.0% (LIF), for the management of dry eye disease (DED). PATIENTS AND METHODS: Patients with DED were recruited via physician referral to pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	White, Darrell E, Zhao, Yang, Jayapalan, Hemalatha, Machiraju, Pattabhi, Periyasamy, Ramu, Ogundele, Abayomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089601/ https://www.ncbi.nlm.nih.gov/pubmed/32256045 http://dx.doi.org/10.2147/OPTH.S233194

Ejemplares similares

Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease
por: White, Darrell E, et al.
Publicado: (2020)

Metabolic Acidosis in Preterm Infants is Associated with a Longer Length of Stay in the Neonatal Intensive Care Unit
por: Paul, Marika, et al.
Publicado: (2020)

Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
por: White, Darrell E, et al.
Publicado: (2019)

The Prevalence and Incidence of Dry Eye Disease Among Patients Using Continuous Positive Airway Pressure or Other Nasal Mask Therapy Devices to Treat Sleep Apnea
por: Matossian, Cynthia, et al.
Publicado: (2020)

Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease
por: Burade, Vinod, et al.
Publicado: (2020)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits
por: Ogundele, Abayomi B, et al.
Publicado: (2010)

Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
por: Ogundele, Abayomi B, et al.
Publicado: (2010)

Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study
por: Labetoulle, Marc, et al.
Publicado: (2018)

Dry eye disease: A review of anti-inflammatory therapies
por: Nguyen, Annie, et al.
Publicado: (2023)

Anti‐Oxidative and Anti‐Inflammatory Micelles: Break the Dry Eye Vicious Cycle
por: Li, Su, et al.
Publicado: (2022)

Effects of Topical Thymoquinone in an Experimental Dry Eye Model
por: Kocatürk, Tolga, et al.
Publicado: (2018)

Dry eye disease immune responses and topical therapy
por: McMonnies, Charles W.
Publicado: (2019)

Topical Spironolactone in the Treatment of Evaporative Dry Eye Disease
por: Wong, Calvin W, et al.
Publicado: (2023)

Inflammatory Cytokine and Osmolarity Changes in the Tears of Dry Eye Patients Treated with Topical 1% Methylprednisolone
por: Lee, Ji Hwan, et al.
Publicado: (2014)

Dry eye disease among Glaucoma patients on topical hypotensive medications, in a tertiary hospital, Ethiopia
por: Sahlu, Miraf, et al.
Publicado: (2021)

Tear biomarkers in dry eye disease: Progress in the last decade
por: Kumar, Nimisha R, et al.
Publicado: (2023)

Anti-inflammatory effects of glycine thymosin β4 eye drops in experimental dry eye
por: Jin, Rujun, et al.
Publicado: (2020)

A murine model of dry eye induced by topical administration of erlotinib eye drops
por: Yang, Qi-Chen, et al.
Publicado: (2018)

Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulium toxin B-induced murine dry eye model
por: Zhu, Lei, et al.
Publicado: (2012)

Dry Eye: an Inflammatory Ocular Disease
por: Hessen, Michelle, et al.
Publicado: (2014)

Patients’ Satisfaction with Topical Anti-Glaucoma Medications and Associated Factors at Gondar University Tertiary Eye Care and Training Center, Northwest Ethiopia, 2021
por: Belie, Natnael Yeneneh, et al.
Publicado: (2023)

PERSIST: Physician’s Evaluation of Restasis(®) Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review
por: Mah, Francis, et al.
Publicado: (2012)

The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options
por: Periman, Laura M., et al.
Publicado: (2020)

Role of topical and systemic immunosuppression in aqueous-deficient dry eye disease
por: Kate, Anahita, et al.
Publicado: (2023)

Effect of topical 3% diquafosol sodium on eyes with dry eye disease and meibomian gland dysfunction
por: Amano, Shiro, et al.
Publicado: (2017)

Topical Delivery of Levocarnitine to the Cornea and Anterior Eye by Thermosensitive in-situ Gel for Dry Eye Disease
por: Ma, Baorui, et al.
Publicado: (2021)

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca
por: Sheppard, John, et al.
Publicado: (2021)

Development of In Vitro Dry Eye Models to Study Proliferative and Anti-Inflammatory Effects of Allogeneic Serum Eye Drops
por: Voß, Silja, et al.
Publicado: (2023)

Managing Sjögren’s Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy
por: Coursey, Terry G, et al.
Publicado: (2014)

The Role of Medications in Causing Dry Eye
por: Fraunfelder, Frederick T., et al.
Publicado: (2012)

A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation.
por: Ogundele, M O
Publicado: (1998)

A mouse dry eye model induced by topical administration of benzalkonium chloride
por: Lin, Zhirong, et al.
Publicado: (2011)

The Effect of Topical Cyclosporine 0.05% on Dry Eye after Cataract Surgery
por: Chung, Yeon Woong, et al.
Publicado: (2013)

Differential response to topical lubrication in patient with dry eye disease, based on age
por: Chen, Yingxin, et al.
Publicado: (2022)

Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease
por: Yeu, Elizabeth, et al.
Publicado: (2019)

Efficacy of Topical Hydrocortisone in Combination with Topical Ciclosporin A for the Treatment of Dry Eye Disease in Patients with Sjögren Syndrome
por: Fondi, Klemens, et al.
Publicado: (2021)

Anti-inflammatory effect of hydroxyproline-GQDGLAGPK in desiccation stress-induced experimental dry eye mouse
por: Lee, Hyesook, et al.
Publicado: (2017)

Anti-inflammatory and antioxidative effects of gallic acid on experimental dry eye: in vitro and in vivo studies
por: Li, Kexin, et al.
Publicado: (2023)

Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation
por: Mullick, Ritika, et al.
Publicado: (2021)

Corrigendum to “The Role of Medications in Causing Dry Eye”
por: Fraunfelder, Frederick T., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5bl121epff88ohvg264ooeb5e5